Serina Therapeutics, Inc.
SER- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001708599
In the last 90 days, Serina Therapeutics, Inc. insiders filed 1 open-market purchase and 0 sales; 27 institutions reported holding it in 13F filings for Q2 2026, worth $2.73M in total; no superinvestor holds it.
Q4 2024 vs. Q3 2024
How the institutions holding Serina Therapeutics, Inc. changed between Q3 2024 and Q4 2024.
All holders in Q4 2024All holders in Q3 2024
| Measure | Q3 2024 | Q4 2024 | Change |
|---|---|---|---|
| Holders | 25 | 25 | 0 |
| Shares | 300.0K | 319.1K | +19.1K (+6.4%) |
| Value | $2.01M | $1.60M | −$408.0K (−20.3%) |
New holders (2)
Institutions that held Serina Therapeutics, Inc. at the end of Q4 2024 but not at the end of Q3 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| SBI Securities Co., Ltd. | 100 | $501 | 0.00% |
| Ameriflex Group, Inc. | 2 | $9 | 0.00% |
Sold out (2)
Institutions that held Serina Therapeutics, Inc. at the end of Q3 2024 and filed for Q4 2024 without it.
| Institution | Shares, Q3 2024 | Value, Q3 2024 |
|---|---|---|
| Danske Bank A/S | 2 | $13 |
| Reuter James Wealth Management, LLC | 2 | $13 |